undamentalytics Newsletter
Sign in

Incyte cash flow statement

In fiscal 2025, Incyte's operations generated $1.41bn of cash; it spent $0 on capital projects, leaving free cash flow of $1.41bn.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations1298−162−9592689305−93336711−1257499704963351,413745
Depreciation and amortisation172427302941455852555552586883899398
Stock-based pay1015293838627096133148167178183188216266249263
Capital spending0443428261201117378187181780000
Free cash flow1294−166−985−263184−204263633−3125688924963351,413745
Free cash flow after stock pay279−194−136−33−64−688−337115466−490385704281691,164482
Share buybacks—————————————002,0050—
Shares issued132———————649—————————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ARGX vs INCYINCY vs NBIXBIIB vs INCY

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Incyte's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Incyte.